Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2014-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53a5b5e6ceed8d4da8eb5a154037e706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cab01eef9c215390d017cc14d921347d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eed7b645122aeb0eee3b185fd04bfc55 |
publicationDate |
2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2014309788-A1 |
titleOfInvention |
Novel quinoline-substituted compound |
abstract |
The problem to be solved by the present invention is to provide: a novel compound which has an EGFR-inhibiting activity and also has a cell proliferation-inhibiting effect; and a medicine which has an EGFR-inhibiting activity and is therefore useful for the prevention and/or treatment of cancer. The present invention provides a compound represented by general formula (I) or a salt thereof. |
priorityDate |
2013-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |